KOLs working with Pharmacyclics An Abbvie
13 key opinion leaders with clinical trial sponsorships or reported industry payments from Pharmacyclics An Abbvie. Relationships are drawn from ClinicalTrials.gov sponsor records and CMS Open Payments, with every number cited to its source.
Profiles
David Spigel, MD
Sarah Cannon Research Institute
- 909
- publications
- 99
- h-index
- 39
- trials
Howard Burris, MD
Sarah Cannon Research Institute
- 1,155
- publications
- 117
- h-index
- 27
- trials
Robert Orlowski, MD
The University of Texas MD Anderson Cancer Center
- 1,164
- publications
- 102
- h-index
- 10
- trials
Rafael Fonseca, MD
Mayo Clinic
- 894
- publications
- 121
- h-index
- 3
- trials
David Siegel, MD
John Theurer Cancer Center
- 699
- publications
- 83
- h-index
- 9
- trials
Christopher Flowers, MD
The University of Texas MD Anderson Cancer Center
- 1,171
- publications
- 83
- h-index
- 4
- trials
Stephen Schuster, MD
Perelman School of Medicine at the University of Pennsylvania
- 804
- publications
- 77
- h-index
- 11
- trials
Paul Barr, MD
University of Rochester Medical Center
- 837
- publications
- 55
- h-index
- 32
- trials
Jesus Berdeja, MD
Sarah Cannon Research Institute
- 531
- publications
- 59
- h-index
- 9
- trials
Matthew Davids, MD
Dana-Farber Cancer Institute
- 653
- publications
- 61
- h-index
- 9
- trials
Charalambos Andreadis, MD
University of California, San Francisco (UCSF)
- 304
- publications
- 43
- h-index
- 7
- trials
Alex Herrera, MD
City of Hope National Medical Center
- 564
- publications
- 47
- h-index
- 14
- trials
Alexey Danilov, MD
City of Hope National Medical Center
- 632
- publications
- 41
- h-index
- 14
- trials
Filter, sort, and export all 13 working with Pharmacyclics An Abbvie in the directory